In a study, Ma et al. found that inflammatory cytokines were lower in hemodialysis patients with COVID-19 than in other patients.12 Another important factor is related to the decreased serum activity of the angiotensin-converting enzyme (ACE2) being prevalent in hemodialysis patients.13 The gene discussed is ACE2; the disease is COVID-19.